Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02435680
Title Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)
Acronym TNBC
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT | AUS

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Massachusetts General Hospital Cancer Center SC Boston Massachusetts 02114 United States Details
Novartis Investigative Site Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Vienna A-1090 Austria Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Saint-Herblain Cédex 44805 France Details
Novartis Investigative Site Berlin 10967 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Hong Kong SAR Hong Kong Details
Novartis Investigative Site Bologna 40138 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Santiago de Compostela Galicia 15706 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Istanbul 35100 Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field